Strategies for management of Clostridium difficile infection in immunosuppressed patients.
作者信息
Binion David G
机构信息
Inflammatory Bowel Disease Center Director of Translational Inflammatory Bowel Disease Research University of Pittsburgh Pittsburgh, Pennsylvania, USA.
出版信息
Gastroenterol Hepatol (N Y). 2011 Nov;7(11):750-2.
Abstract
摘要
相似文献
1
Strategies for management of Clostridium difficile infection in immunosuppressed patients.免疫抑制患者艰难梭菌感染的管理策略
Gastroenterol Hepatol (N Y). 2011 Nov;7(11):750-2.
2
Serum markers for severe Clostridium difficile infection in immunosuppressed hospitalized patients.免疫抑制住院患者中严重艰难梭菌感染的血清标志物
J La State Med Soc. 2011 Mar-Apr;163(2):91-4.
3
Clostridium difficile infection in low- and middle-human development index countries: a systematic review.低人类发展指数和中等人类发展指数国家中的艰难梭菌感染：一项系统评价
Trop Med Int Health. 2017 Oct;22(10):1223-1232. doi: 10.1111/tmi.12937. Epub 2017 Aug 31.
4
A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.一项关于甲硝唑和万古霉素用于治疗血液系统恶性肿瘤患者艰难梭菌感染的回顾性研究。
J Oncol Pharm Pract. 2014 Jun;20(3):172-82. doi: 10.1177/1078155213490004. Epub 2013 Jun 26.
5
[Immunosuppressive treatment as a risk factor for the occurrence of clostridium difficile infection (CDI)].[免疫抑制治疗作为艰难梭菌感染（CDI）发生的一个风险因素]
Z Gastroenterol. 2013 Nov;51(11):1251-8. doi: 10.1055/s-0033-1335505. Epub 2013 May 21.
6
Fecal Bacteriotherapy: A Case Report in an Immunosuppressed Patient with Ulcerative Colitis and Recurrent Clostridium difficile Infection.粪便细菌疗法：1例免疫抑制性溃疡性结肠炎合并复发性艰难梭菌感染患者的病例报告
Case Rep Infect Dis. 2012;2012:810943. doi: 10.1155/2012/810943. Epub 2012 Apr 23.
7
Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients.炎症性肠病儿童与肿瘤和免疫功能正常患者相比艰难梭菌感染的发生率。
Digestion. 2012;86(1):6-11. doi: 10.1159/000337357. Epub 2012 Jun 8.
8
New drugs and strategies for management of Clostridium difficile colitis.艰难梭菌结肠炎的新药及治疗策略
J Intensive Care Med. 2014 Jul-Aug;29(4):190-9. doi: 10.1177/0885066613475426. Epub 2013 Feb 7.
9
The Daniel K. Inouye College of Pharmacy Scripts: Updates on Infection: Advances in Laboratory Testing to Aid Diagnosis and Treatment.丹尼尔·K·伊努耶药学院文稿：感染最新情况：辅助诊断和治疗的实验室检测进展
Hawaii J Med Public Health. 2017 Feb;76(2):59-64.
10
Mortality and Clostridium difficile infection in an Australian setting.在澳大利亚环境中的死亡率和艰难梭菌感染。
J Adv Nurs. 2013 Oct;69(10):2162-70. doi: 10.1111/jan.12078. Epub 2013 Jan 7.
引用本文的文献
1
Community-Acquired Infection: The Fox Among the Chickens.社区获得性感染：鸡群中的狐狸
Int J Mol Sci. 2025 May 14;26(10):4716. doi: 10.3390/ijms26104716.
2
Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease.嵌套病例对照研究炎症性肠病患者机会性感染的危险因素。
World J Gastroenterol. 2019 May 14;25(18):2240-2250. doi: 10.3748/wjg.v25.i18.2240.
3
Toxigenic isolates from clinically significant diarrhoea in patients from a tertiary care centre.从一家三级护理中心的临床显著腹泻患者中分离出产毒株。
Indian J Med Res. 2017 Jun;145(6):840-846. doi: 10.4103/ijmr.IJMR_192_16.
4
An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel Disease.对诊断为炎症性肠病患者样本中的 AGA 和 CCFA 质量指标的评估。
J Manag Care Spec Pharm. 2015 Nov;21(11):1064-76. doi: 10.18553/jmcp.2015.21.11.1064.
5
Preventing infective complications in inflammatory bowel disease.预防炎症性肠病中的感染性并发症
World J Gastroenterol. 2014 Aug 7;20(29):9691-8. doi: 10.3748/wjg.v20.i29.9691.
本文引用的文献
1
Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.非达霉素：一种用于治疗艰难梭菌感染的大环内酯类抗生素。
Pharmacotherapy. 2011 Sep;31(9):877-86. doi: 10.1592/phco.31.9.877.
2
Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.艰难梭菌感染与炎症性肠病：综述
Gastroenterol Res Pract. 2011;2011:136064. doi: 10.1155/2011/136064. Epub 2011 Sep 12.
3
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.炎症性肠病和艰难梭菌感染患者内镜下假膜的患病率及临床影响。
J Crohns Colitis. 2010 Jun;4(2):194-8. doi: 10.1016/j.crohns.2009.11.001. Epub 2009 Nov 22.
4
Impact of Clostridium difficile on inflammatory bowel disease.艰难梭菌对炎症性肠病的影响。
Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):589-600. doi: 10.1586/egh.10.55.
5
Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease.炎症性肠病患者中与艰难梭菌感染相关的疾病结局的时间趋势。
Inflamm Bowel Dis. 2011 Apr;17(4):976-83. doi: 10.1002/ibd.21457. Epub 2010 Sep 7.
Zotero 插件